AGR3 and breast carcinoma: Using data of 516 breast cancer patients available at The Cancer Genome Atlas (TCGA) [34] we found pronounced AGR3 mRNA expression in both PAM50 [38] luminal subtypes, i.e. luminal A and B tumours, with a slightly stronger expression in luminal A carcinomas (Fig. 1D).